Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Ann Otol Rhinol Laryngol ; 124(3): 179-86, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25204709

ABSTRACT

OBJECTIVE: This study aimed to analyze the rate of failure, patterns of failure, and prognostic factors for patients who remain intubated after head and neck surgery and then undergo delayed extubation. METHODS: Retrospective chart review of all otolaryngology patients who remained intubated after head and neck surgery and then underwent delayed extubation between 2006 and 2013. The incidence and patterns of extubation failure were analyzed. Univariable logistic regression analysis was performed to identify risk factors for postextubation failure. RESULTS: Fifteen of the 129 patients (12%) who remained intubated after head and neck surgery and underwent delayed extubation subsequently failed and required either repeat intubation or an emergency surgical airway. The most common reasons for failure were hemorrhage (47%) and upper airway edema (33%). Failure typically occurred within 6 hours of extubation. Twenty-seven percent of the patients who failed extubation (4/15) required an emergency surgical airway. On univariable logistic regression analysis, ligation of a major neck vessel predicted extubation failure (odds ratio=5.20; 95% confidence interval, 1.48-18.23). CONCLUSION: Postextubation failure in carefully selected patients undergoing delayed extubation after head and neck surgery is infrequent and most commonly due to postoperative bleeding. Prospective data are required to facilitate safe and quality care for these patients.


Subject(s)
Airway Extubation , Otorhinolaryngologic Surgical Procedures/adverse effects , Postoperative Complications/epidemiology , Respiration, Artificial/methods , Female , Humans , Incidence , Intubation, Intratracheal , Male , Middle Aged , Prognosis , Retrospective Studies , Treatment Failure , United States/epidemiology
2.
Laryngoscope ; 133(3): 576-587, 2023 03.
Article in English | MEDLINE | ID: mdl-35575599

ABSTRACT

OBJECTIVES: Carotid blowout syndrome (CBS) is an acute, rare life-threatening hemorrhage that occurs in patients with a history of head and neck cancer and radiation therapy. The primary objective of this review was to identify risk factors and assess treatment and survival outcomes following CBS. METHODS: A systematic review of published literature was performed. Information including risk factors, treatment, and outcomes of CBS were collected. RESULTS: A total of 49 articles and 2220 patients were included in the systematic review. Risk factors for developing CBS included a history of radiation therapy, wound complications, and advanced tumor stage. The initial management of CBS included establishing a stable airway, gaining hemostasis, and repletion of blood loss. Endovascular and surgical procedures treat CBS with infrequent rates of rebleeding and periprocedural complications. Short-term survival following treatment of CBS shows high survival rates when considering CBS-related complications and underlying disease, however, long-term survival related to the underlying disease demonstrated high mortality. CONCLUSIONS: Identifying patients at risk for CBS enables practitioners to counsel patients on life-saving interventions and expected outcomes following treatment of CBS. Treatment of CBS is associated with high short-term survival, although long-term survival related to underlying disease is low. LEVEL OF EVIDENCE: N/A Laryngoscope, 133:576-587, 2023.


Subject(s)
Carotid Artery Diseases , Head and Neck Neoplasms , Humans , Carotid Artery Diseases/etiology , Stents/adverse effects , Neoplasm Recurrence, Local , Head and Neck Neoplasms/complications , Head and Neck Neoplasms/therapy , Carotid Arteries , Hemorrhage/etiology , Hemorrhage/therapy , Retrospective Studies
3.
JAMA Otolaryngol Head Neck Surg ; 147(2): 190-196, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33270099

ABSTRACT

Importance: Zenker diverticulum (ZD) can cause significant dysphagia, and symptoms can return or persist after surgery. This systematic review and network meta-analysis is the first to our knowledge to compare 3 common surgical techniques for ZD. Objective: To compare the 3 most common surgical techniques-endoscopic laser-assisted diverticulotomy, endoscopic stapler-assisted diverticulotomy, and transcervical diverticulectomy with cricopharyngeal myotomy-in adult patients with ZD. Data Sources: The published literature was searched using strategies designed by a medical librarian (search performed September 21, 2018). Strategies were established using a combination of controlled vocabulary terms and keywords and were executed in Ovid MEDLINE (1946 to September 21, 2018), Embase (1947 to September 21, 2018), Scopus (1823 to September 21, 2018), Cochrane Library, and ClinicalTrials.gov. Results were limited to English using database-supplied filters, which generated studies from 1997 to 2017. Study Selection: Inclusion criteria were cohort studies or randomized clinical trials. Studies that included patients needing revision surgery or undergoing an alternative technique were excluded. Data Extraction and Synthesis: The Preferred Reporting Items for Systematic Reviews and Meta-analyses-Network Meta-analyses (PRISMA-NMA) checklist was used to report the study findings. Two authors independently reviewed the studies. Main Outcome and Measure: The primary outcome measure was the incidence of persistent or recurrent symptoms following surgery. The primary study outcome was planned before data collection began. Results: The search generated 529 studies. After applying inclusion and exclusion criteria, 9 cohort studies remained, consisting of 903 patients treated with either laser-assisted diverticulotomy (n = 283), transcervical diverticulectomy (n = 150), or stapler-assisted diverticulotomy (n = 470). A network meta-analysis was performed. Between endoscopic laser-assisted diverticulotomy and open diverticulectomy, the open approach showed a statistically lower likelihood of persistent/recurrent symptoms following treatment (odds ratio [OR], 0.20; 95% CI, 0.04-0.91). Comparing laser-assisted diverticulotomy with the stapler-assisted technique, there was not a significant difference between the 2 techniques (OR, 0.83; 95% CI, 0.43-1.60). The consistency model for the network meta-analysis was supported (χ21 = 0.12; P = .73). Conclusions and Relevance: This systematic review and meta-analysis compared 3 common techniques for treating ZD. The open approach showed a decreased likelihood of persistent or recurrent symptoms following surgery compared with the 2 other techniques.


Subject(s)
Zenker Diverticulum/surgery , Endoscopy , Humans , Laser Therapy , Myotomy , Postoperative Complications , Recurrence , Reoperation , Surgical Stapling
4.
Auris Nasus Larynx ; 47(5): 837-841, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32241579

ABSTRACT

OBJECTIVE: To describe a novel surgical therapy for the treatment of medically refractory neuropathic cough, in which carefully selected subjects undergo surgical transection of the internal branch of the superior laryngeal nerve (iSLN). METHODS: Subjects with a diagnosis of neuropathic cough, who were not improved after two medication trials, underwent iSLN block with local anesthetic in the office. While anesthetized, they underwent provocative testing to determine whether the nerve block improved their symptoms; if so, a modified barium swallow study (MBSS) was performed to determine whether they still swallowed safely without supraglottic sensation. Those who passed this screening were offered operative iSLN transection. We retrospectively reviewed our results to date. RESULTS: Six subjects (5 females, ages 46-71), with neuropathic cough symptoms for 2-15 years, passed the screening and underwent iSLN transection procedures. At a mean follow-up of 8.2 months, significant symptomatic relief was experienced by 5/6 subjects, with Cough Severity Index (CSI) scores averaging 34.83 ± 6.94 pre-op (range 36-40) and 15.5 ± 11.81 post-op (range 0-29) (p = 0.043). Operative time averaged 49 min (range 30-64). There were no major complications. No subjects experienced post-op aspiration problems. CONCLUSION: This preliminary data supports iSLN transection as a viable option for subjects with refractory neuropathic cough. Our screening algorithm identifies subjects that would be expected to improve with this procedure and confirms a safe swallow.


Subject(s)
Cough/surgery , Laryngeal Nerves/surgery , Aged , Algorithms , Chronic Disease , Cough/etiology , Female , Humans , Male , Middle Aged , Peripheral Nervous System Diseases/complications , Pilot Projects , Retrospective Studies
5.
Ear Nose Throat J ; 98(5): E30-E31, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30961378

ABSTRACT

Vinca alkaloids are known to cause bilateral jaw pain that occurs once during the chemotherapy course. We report a patient with first bite syndrome (FBS) during active treatment with chemotherapy. A patient with Hodgkin lymphoma presented with unilateral jaw pain after beginning his chemotherapy regimen. Pain was worse with the first bite of each meal and dissipated over subsequent bites. Workup was negative for any lesions in the parotid, parapharyngeal space, or infratemporal fossa. Pain was timed closely with chemotherapy administration and would improve prior to next cycle. A trial of botulinum chemodenervation failed to completely relieve symptoms. The patient noted resolution of symptoms after the completion of chemotherapy. We report a case of FBS, which may represent the jaw pain seen commonly with administration of vinca alkaloids. There appears to be a correlation between onset and duration of first bite symptoms with chemotherapy administration.


Subject(s)
Botulinum Toxins, Type A/administration & dosage , Facial Pain , Hodgkin Disease , Vinca Alkaloids , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Facial Pain/chemically induced , Facial Pain/diagnosis , Facial Pain/physiopathology , Facial Pain/therapy , Hodgkin Disease/drug therapy , Hodgkin Disease/pathology , Humans , Male , Neoplasm Staging , Neuromuscular Agents/administration & dosage , Positron Emission Tomography Computed Tomography/methods , Treatment Outcome , Vinca Alkaloids/administration & dosage , Vinca Alkaloids/adverse effects
6.
Laryngoscope ; 129(12): 2744-2747, 2019 12.
Article in English | MEDLINE | ID: mdl-30698821

ABSTRACT

OBJECTIVES/HYPOTHESIS: Injection laryngoplasty has become valuable in treating laryngologic disorders including vocal cord atrophy, paralysis, and paresis. Although materials such as carboxymethylcellulose and calcium hydroxylapatite are Food and Drug Administration (FDA) approved, they are not without limitations. Juvederm (hyaluronic acid) is an alternative treatment that is not FDA approved. Although studies have examined Juvederm's longevity in cutaneous injections, there are limited data examining durability of Juvederm used in laryngoplasty. We aimed to determine the longevity and effectiveness of Juvederm used in injection laryngoplasty. STUDY DESIGN: Retrospective cohort study. METHODS: Subjects who underwent injection laryngoplasty using Juvederm were reviewed. Longevity was defined as the time between injection and the date that a patient first noted subjective deterioration of their voice. All subjects were subsequently followed using videostroboscopy to evaluate for Juvederm resorption. Longevity was analyzed using a Kaplan-Meier survival model, and effectiveness of laryngoplasty was determined using the Voice-Related Quality of Life index scores and analyzed using a Wilcoxon signed ranks test. RESULTS: Fifty-nine subjects met inclusion criteria and underwent Juvederm injection laryngoplasty. Kaplan-Meier survival analysis revealed a mean longevity of 10.6 months (95% confidence interval: 9.1-12.0 months). Wilcoxon signed ranks analysis of the pre- and postinjection Voice Related Quality of Life (VRQOL) scores revealed improvement, with a mean preinjection VRQOL of 49.2 (standard deviation [SD] = 25.8) and mean postinjection VRQOL of 68.2 (SD = 27.5) (P < .001). CONCLUSIONS: Injection laryngoplasty using Juvederm is an effective treatment for vocal cord atrophy, paralysis, and paresis. Knowledge of the patient-defined duration of benefit following laryngoplasty using Juvederm plays an important role in counseling patients as well as in the planning of future interventions. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:2744-2747, 2019.


Subject(s)
Hyaluronic Acid/analogs & derivatives , Laryngoplasty/methods , Quality of Life , Vocal Cord Paralysis/surgery , Voice Quality/physiology , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Hyaluronic Acid/administration & dosage , Injections , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Viscosupplements , Vocal Cord Paralysis/physiopathology , Young Adult
7.
Article in English | MEDLINE | ID: mdl-36227601

ABSTRACT

A 68-year-old man with heart disease and obesity who had undergone surgery for cervical spondylotic myelopathy presented with difficulty breathing. What is your diagnosis?

8.
J Voice ; 31(3): 363-365, 2017 May.
Article in English | MEDLINE | ID: mdl-27839987

ABSTRACT

OBJECTIVES: This study aimed to identify the changes in dosing of botulinum toxin-A for adductor spasmodic dysphonia (ADSD) over a prolonged period. STUDY DESIGN: This is a retrospective chart review. METHODS: One hundred thirteen subjects treated for ADSD from 2003 to 2013 were identified from a clinical database. Subject age, gender, and total injection dose amount were all recorded for all subjects who had at least 10 injections. RESULTS: Fifty-four subjects met criteria for inclusion. There were no age or gender differences in the starting dose for subjects. Dosing decreased significantly compared with the second dose (5.05 ± 1.623 Units), by the sixth dose (4.26 ± 1.698 Units), and continued through the 10th dose (4.08 ± 2.019 Units) (P < 0.005 for all). CONCLUSIONS: Botulinum toxin-A dosing for ADSD decreases consistently over subsequent injections after the initial two dose titrations.


Subject(s)
Acetylcholine Release Inhibitors/administration & dosage , Botulinum Toxins, Type A/administration & dosage , Dysphonia/drug therapy , Laryngeal Muscles/drug effects , Acetylcholine Release Inhibitors/adverse effects , Botulinum Toxins, Type A/adverse effects , Dysphonia/diagnostic imaging , Dysphonia/physiopathology , Female , Georgia , Humans , Injections, Intramuscular , Laryngeal Muscles/diagnostic imaging , Laryngeal Muscles/physiopathology , Male , Middle Aged , Recovery of Function , Retrospective Studies , Stroboscopy , Time Factors , Treatment Outcome , Video Recording
9.
J Voice ; 30(6): 774.e9-774.e12, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26743607

ABSTRACT

OBJECTIVE: The aim of this study was to describe a case of colorectal carcinoma metastatic to the larynx and provide a review of the current literature. METHODS: A case report with chart review was performed. A review of the current literature was performed by systematically searching PubMed, OVID, CINAHL Plus, and EMBASE. RESULTS: In 1988, a comprehensive literature review identified melanoma as the most common neoplasm to exhibit laryngeal involvement. Since that study, 41 subsequent cases have been reported, and among these, colorectal adenocarcinoma was the most frequent distant primary (24%). In 25 (58%) cases, curative surgery was attempted, but only 4 patients remained disease-free at last follow up. We report the history of a 52-year-old man who presented with rectal adenocarcinoma metastatic to his larynx 4 years after definitive treatment of the primary site. CONCLUSIONS: In patients with a laryngeal mass and a history of colorectal cancer, or those at high risk of having an occult colorectal primary, metastatic spread to the larynx must always be considered. Although secondary laryngeal metastasis portends a poor prognosis, for the select patient, surgical intervention can provide long-term disease control.


Subject(s)
Adenocarcinoma/secondary , Colorectal Neoplasms/pathology , Laryngeal Neoplasms/secondary , Adenocarcinoma/therapy , Biopsy , Chemoradiotherapy , Colorectal Neoplasms/therapy , Humans , Laryngeal Neoplasms/therapy , Male , Middle Aged , Palliative Care , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
11.
Otol Neurotol ; 32(8): 1336-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21897322

ABSTRACT

OBJECTIVE: To describe the phenomenon of hyperventilation-induced nystagmus (HVN) after stereotactic radiotherapy for vestibular schwannoma. PATIENTS: We present 2 patients with vestibular schwannoma and no pretreatment vestibular symptoms who both received stereotactic radiotherapy. Within 2 months of completing treatment, both patients developed intense vertigo while exerting themselves. Video-oculography demonstrated an intense nystagmus with the fast phase directed toward the side of the schwannoma in both patients. INTERVENTION: Diagnostic. RESULTS: Patients who have undergone surgical resection of their vestibular schwannoma, or have a large tumor, will often demonstrate HVN with the fast phase directed away from the side of the tumor. This is distinct from patients with smaller lesions who have a fast-phase nystagmus toward the tumor's side. This second type of nystagmus is thought to originate from changes in the extracellular calcium concentration secondary to hyperventilation-induced alkalosis. CONCLUSION: We hypothesize that stereotactic radiotherapy induced greater demyelination of the vestibular nerve leading to the observable sign of HVN. These patients represent the first reported cases of HVN after stereotactic radiation and illustrate the pathophysiology of HVN, which may lead to a greater understanding of the effects of stereotactic radiotherapy.


Subject(s)
Hyperventilation/etiology , Neuroma, Acoustic/surgery , Nystagmus, Pathologic/etiology , Radiosurgery/adverse effects , Vertigo/etiology , Female , Humans , Hyperventilation/physiopathology , Nystagmus, Pathologic/physiopathology , Vertigo/physiopathology , Vestibular Function Tests , Vestibular Nerve/physiopathology
12.
Laryngoscope ; 121(11): 2406-10, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21994176

ABSTRACT

OBJECTIVES/HYPOTHESIS: The primary objective of this study was to evaluate the effectiveness and safety of injection laryngoplasty using a temporary injectable agent in the acute setting for patients with unilateral vocal cord paralysis following thoracic surgical procedures. STUDY DESIGN: Retrospective consecutive case series in an academic institution. METHODS: Inclusion criteria included patients acutely treated with injection laryngoplasty from January 1, 2006, to March 31, 2010, for a unilateral vocal cord paralysis that occurred after a thoracic surgical procedure (N = 20). All patients were injected with Radiesse Voice Gel using microlaryngoscopy technique. RESULTS: The mean time to vocal cord injection from the time of thoracic surgery was 4.5 days. There was one operative-related complication of intraoperative bile reflux that caused a pneumonitis. Ninety percent of patients were recommended for strict nothing by mouth prior to injection. Of these, 94% were allowed an oral diet following injection, and 67% tolerated a regular diet. None of the patients required subsequent procedures for aspiration or dysphagia, and 25% required further intervention after discharge for persistent dysphonia. Patients with a known nerve transection had a higher rate of dysphonia requiring further surgical procedures than those who did not have a known nerve transection. CONCLUSIONS: Acute treatment of thoracic surgery-related unilateral vocal cord paralysis with injection laryngoplasty appears safe and effective at preventing postoperative aspiration pneumonia and improves swallowing function to allow resumption of an oral diet. A single injection is often the only required treatment.


Subject(s)
Carboxymethylcellulose Sodium/administration & dosage , Laryngoplasty/methods , Microsurgery/methods , Postoperative Complications/surgery , Thoracic Surgical Procedures/adverse effects , Vocal Cord Paralysis/surgery , Adult , Aged , Esophagectomy/adverse effects , Female , Humans , Injections , Male , Middle Aged , Pneumonectomy/adverse effects , Retrospective Studies , Treatment Outcome , Young Adult
13.
Otolaryngol Head Neck Surg ; 142(1): 6-14, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20096216

ABSTRACT

A systematic review is a transparent and unbiased review of available information. The published systematic review must report the details of the conduct of the review as one might report the details of a primary research project. A meta-analysis is a powerful and rigorous statistical approach to synthesize data from multiple studies, preferably obtained from a systematic review, in order to enlarge the sample size from smaller studies to test the original hypothesis and/or to generate new ones. The objective of this article is to serve as an easy to read practical guide to understand systematic reviews and meta-analyses for those reading them and for those who might plan to prepare them.


Subject(s)
Meta-Analysis as Topic , Review Literature as Topic , Guidelines as Topic
15.
Pediatrics ; 115(1): e7-14, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15629968

ABSTRACT

OBJECTIVE: Respiratory syncytial virus (RSV) bronchiolitis is a common cause of hospitalizations in children and has been increasingly identified as a risk factor in the development of asthma. Little is known about what determines the severity of RSV bronchiolitis, which may be helpful in the initial assessment of these children. DESIGN: We evaluated a variety of environmental and host factors that may contribute to the severity of RSV bronchiolitis in the RSV Bronchiolitis in Early Life prospective cohort study. Severity of bronchiolitis was based on the quantization of lowest O(2) saturation and the length of stay. These factors included the child's and family's demographics, presence of household allergens (dust mite, cat, dog, and cockroach), peripheral blood eosinophil count, immunoglobulin E level, infant feeding, prior illnesses, exposure to intrauterine and postnatal cigarette smoke, and family history of atopy. PATIENTS: We prospectively enrolled 206 hospitalized infants, all under 12 months old (4.0 +/- 3.3 months old), with their first episode of severe RSV bronchiolitis (mean O(2) saturation: 91.6 +/- 7.3%; length of stay: 2.5 +/- 2.5 days; presence of radiographic opacities: 75%). Patients were excluded for a variety of reasons including previous wheezing, regular use of bronchodilator or antiinflammatory medications, any preexisting lung disease including asthma, chronic lung disease of prematurity/bronchopulmonary dysplasia, or cystic fibrosis; gastroesophageal reflux disease on medical therapy; or congenital anomalies of the chest or lung. RESULTS: Age was found to be a significant factor in the severity of infection. The younger an infant was, the more severe the infection tended to be as measured by the lowest oxygen (O(2)) saturation. We also found that infants exposed to postnatal cigarette smoke from the mother had a lower O(2) saturation than those not exposed. However, there was no significant difference in RSV bronchiolitis severity between infants exposed only to intrauterine smoke and those infants never exposed to cigarette smoke. Infants with a family history of atopy, especially a maternal history of asthma or hay fever, had a higher O(2) saturation. Although a history of maternal atopy seemed to be protective, there was no association between allergens and bronchiolitis severity, although 25% of households had elevated allergen levels. Black infants demonstrated less severe RSV bronchiolitis than their white counterparts. Multivariate analysis revealed age, race, maternal atopy, and smoking to be associated with severity of RSV bronchiolitis. CONCLUSION: The severity of RSV bronchiolitis early in life seems modified by postnatal maternal cigarette smoke exposure and atopy and age of the infant, not by levels of allergens in the home environment.


Subject(s)
Bronchiolitis, Viral/classification , Hypersensitivity/genetics , Respiratory Syncytial Virus Infections/classification , Tobacco Smoke Pollution/adverse effects , Age Factors , Allergens/adverse effects , Asthma/genetics , Bronchiolitis, Viral/complications , Bronchiolitis, Viral/ethnology , Environmental Exposure , Female , Hospitalization , Humans , Infant , Infant, Newborn , Male , Maternal Exposure , Multivariate Analysis , Oxygen/blood , Prospective Studies , Respiratory Syncytial Virus Infections/complications , Respiratory Syncytial Virus Infections/ethnology , Respiratory Syncytial Virus, Human , Rhinitis, Allergic, Seasonal/genetics , Severity of Illness Index
16.
Am J Respir Crit Care Med ; 169(7): 842-9, 2004 Apr 01.
Article in English | MEDLINE | ID: mdl-14726420

ABSTRACT

We reasoned that a prospective assessment of glucocorticoid withdrawal in subjects with asthma would provide insight into the basis for flares of the disease. We therefore enrolled 25 subjects with moderate persistent asthma and treated them for 30 days with inhaled fluticasone propionate (1,760 microg/day) followed by a withdrawal period that lasted until peak expiratory airflow decreased by 25% and FEV(1) by 15% or 6 weeks elapsed. After glucocorticoid withdrawal, 13 of 25 subjects reached the target, whereas 12 subjects did not. The number of eosinophils in bronchial biopsies was increased by glucocorticoid withdrawal in both groups, but increases in airway T cells were found in only those with exacerbation. T-cell accumulation was a reflection of similar increases in both CD4(+) and CD8(+) T cells and was accompanied by increased expression of chemokine CCL5 (regulated upon activation, normal T cell expressed and secreted) in the airway epithelium without activation of the transcription factor nuclear factor-kappaB. The pattern of glucocorticoid-sensitive inflammation during an asthma exacerbation is more reminiscent of an antiviral response than an eosinophil-predominant response to allergen and implies an independent role for airway T cells in mediating asthma flares and in determining glucocorticoid efficacy in the treatment of this disease.


Subject(s)
Androstadienes/pharmacology , Anti-Inflammatory Agents/pharmacology , Asthma/drug therapy , Asthma/immunology , Respiratory Mucosa/drug effects , T-Lymphocytes/drug effects , Adult , Aged , Chemokine CCL5/metabolism , Chemokines, CC/metabolism , Eosinophils/drug effects , Eosinophils/metabolism , Female , Fluticasone , Humans , Male , Middle Aged , NF-kappa B/drug effects , NF-kappa B/metabolism , Respiratory Mucosa/immunology , Respiratory Mucosa/pathology , T-Lymphocytes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL